Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br J Clin Pharmacol ; 84(6): 1121-1127, 2018 06.
Artigo em Inglês | MEDLINE | ID: mdl-29498758

RESUMO

Vitamin D is a particularly important sterol hormone, with evidence emerging of its beneficial effects well beyond bone. In consequence of this and increased global recognition of vitamin D deficiency in the general population, there has been a resurgence in treatment with vitamin D preparations. However, the increasing use of vitamin D treatments has also seen a substantial increase in the number of reports of vitamin D intoxication, with the majority (75%) of reports published since 2010. Many of these cases are a consequence of inappropriate prescribing, and the use of high-dose over-the-counter preparations or unlicensed preparations. This review highlights that the majority of cases were preventable and discusses the inappropriate use of poorly formulated, and unlicensed vitamin D preparations.


Assuntos
Suplementos Nutricionais , Uso Indevido de Medicamentos/efeitos adversos , Prescrição Inadequada/efeitos adversos , Medicamentos sem Prescrição/efeitos adversos , Deficiência de Vitamina D/tratamento farmacológico , Vitamina D/efeitos adversos , Suplementos Nutricionais/efeitos adversos , Relação Dose-Resposta a Droga , Composição de Medicamentos , Humanos , Medição de Risco , Fatores de Risco , Vitamina D/administração & dosagem , Vitamina D/sangue , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/diagnóstico
2.
Br J Neurosurg ; 30(1): 76-9, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26313503

RESUMO

BACKGROUND: Assessment of adrenal reserve in patients who have undergone pituitary surgery is crucial. However, there is no clear consensus with regards to the type and timing of the test that should be used in the immediate post-operative period. Recently, there has been increased interest in measuring post-operative cortisol levels. We present our data utilising day 1 post-operative early morning cortisol as a tool to assess adrenal reserve in steroid-naive patients. METHODS: A retrospective analysis of endoscopic pituitary surgery undertaken over a 2-year period. 82 patients underwent 84 surgeries in total. Patients who were already on glucocorticoids pre-operatively and patients with Cushing's disease, pituitary apoplexy and those without follow-up data were excluded, leaving a study group of 44 patients with 45 operations. A 9am day 1 post-operative cortisol value of > 400 nmol/L was taken as an indicator of adequate adrenal reserve. All the patients were reassessed at 6 weeks with a standard short synacthen test (SST) using 250 micrograms of intravenous synacthen. RESULTS: 22 out of 45 patients had a cortisol value of > 400 nmol/L on day 1 post-operatively and were discharged without glucocorticoid supplementation. Of these, only 2 patients subsequently failed the SST when reassessed at 6-8 weeks. The remaining 23 patients had a cortisol value of < 400 nmol/L on day 1 post-operatively and were discharged on hydrocortisone 10 mg twice daily. At 6-8 weeks, nine continued to show suboptimal stimulated cortisol levels whereas the remaining fourteen patients showed adequate adrenal reserve. The 9 am cortisol value had high specificity (81.8%) and positive predictive value (90.9%) for integrity of the HPA axis. Sensitivity was 58.8% and negative predictive value was 39.1%. CONCLUSION: A day 1 post-operative early morning cortisol is a useful tool to predict adrenal reserve post-pituitary surgery, enabling clinicians to avoid unnecessary blanket glucocorticoid replacement.


Assuntos
Glucocorticoides/sangue , Hidrocortisona/sangue , Doenças da Hipófise/cirurgia , Adulto , Idoso , Feminino , Seguimentos , Humanos , Hidrocortisona/metabolismo , Sistema Hipotálamo-Hipofisário/metabolismo , Masculino , Pessoa de Meia-Idade , Doenças da Hipófise/diagnóstico , Sistema Hipófise-Suprarrenal/metabolismo , Cuidados Pós-Operatórios , Valor Preditivo dos Testes , Estudos Retrospectivos , Adulto Jovem
4.
J Endocrinol Invest ; 37(9): 811-7, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24957166

RESUMO

PURPOSE: Vitamin D is a relatively inexpensive drug yet an important hormone in terms of calcium and bone homeostasis. Treatment with vitamin D is associated with reduced fracture risk particularly in an elderly population. Therefore, we assessed the budgetary impact of routine prescription of 800 IU daily colecalciferol on hip fracture among older adults in the United Kingdom. METHODS: Using meta-analysis findings for treatment effect and UK-estimates of incidence, we performed a health economic evaluation of treating the UK population aged 65 and over with 800 IU of vitamin D daily, assessing the impact upon hip fracture costs using incremental attributable costs and excess mortality for a range of age- gender-based treatment strategies. RESULTS: Using only a 1-year horizon, considering only reduction in hip fracture, prescribing colecalciferol 800 IU daily to all adults aged 65 and over, could reduce the number of incident hip fractures from 65,400 to 45,700, saving almost 1,700 associated deaths, whilst saving the UK taxpayer £22 million. CONCLUSIONS: As the UK government seeks to reduce public expenditure in all sectors, investment in prescribed prophylactic colecalciferol 800 IU therapy for adults aged 65 and over is likely to yield cost savings through reduction hip fracture alone in the first year.


Assuntos
Conservadores da Densidade Óssea/administração & dosagem , Colecalciferol/administração & dosagem , Custos de Cuidados de Saúde/estatística & dados numéricos , Fraturas do Quadril/prevenção & controle , Programas de Assistência Gerenciada/normas , Idoso , Idoso de 80 Anos ou mais , Conservadores da Densidade Óssea/economia , Colecalciferol/economia , Feminino , Fraturas do Quadril/economia , Humanos , Masculino , Programas de Assistência Gerenciada/economia , Fatores de Tempo , Reino Unido
6.
Vasc Health Risk Manag ; 2(1): 19-30, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17319466

RESUMO

Initially considered as a semipermeable barrier separating lumen from vessel wall, the endothelium is now recognised as a complex endocrine organ responsible for a variety of physiological processes vital for vascular homeostasis. These include the regulation of vascular tone, luminal diameter, and blood flow; hemostasis and thrombolysis; platelet and leucocyte vessel-wall interactions; the regulation of vascular permeability; and tissue growth and remodelling. The endothelium modulates arterial stiffness, which precedes overt atherosclerosis and is an independent predictor of cardiovascular events. Unsurprisingly, dysfunction of the endothelium may be considered as an early and potentially reversible step in the process of atherogenesis and numerous methods have been developed to assess endothelial status and large artery stiffness. Methodology includes flow-mediated dilatation of the brachial artery, assessment of coronary flow reserve, carotid intima/media thickness, pulse wave analysis, pulse wave velocity, and plethysmography. This review outlines the various modalities, indications, and limitations of available methods to assess arterial dysfunction and vascular risk.


Assuntos
Aterosclerose/diagnóstico , Artéria Braquial/fisiopatologia , Angiografia Coronária , Endotélio Vascular/fisiopatologia , Pletismografia , Ultrassonografia de Intervenção , Aterosclerose/complicações , Aterosclerose/metabolismo , Aterosclerose/patologia , Aterosclerose/fisiopatologia , Biomarcadores/metabolismo , Fatores de Coagulação Sanguínea/metabolismo , Velocidade do Fluxo Sanguíneo , Doenças Cardiovasculares/etiologia , Artérias Carótidas/diagnóstico por imagem , Angiografia Coronária/métodos , Citocinas/metabolismo , Elasticidade , Células Endoteliais/patologia , Endotélio Vascular/patologia , Humanos , Lipoproteínas LDL/metabolismo , Pletismografia/métodos , Pulso Arterial , Fluxo Sanguíneo Regional , Medição de Risco , Fatores de Risco , Células-Tronco/patologia , Túnica Íntima/diagnóstico por imagem , Ultrassonografia de Intervenção/métodos , Vasodilatação
7.
Fertil Steril ; 82(6): 1672-4, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15589877

RESUMO

OBJECTIVE: To report improvement of azoospermia and hypogonadism after high-dose corticosteroid therapy in a patient with testicular sarcoidosis. DESIGN: Case report. SETTING: University hospital. PATIENT(S): A 27-year-old man with testicular sarcoidosis and azoospermia. INTERVENTION(S): High-dose corticosteroid therapy was commenced in an attempt to improve sperm count and restore gonadal function. MAIN OUTCOME MEASURE(S): Analysis of sperm count, T, and gonadotropin response to steroid therapy. RESULT(S): FSH and LH concentrations decreased and T levels increased in parallel with control of disease activity with steroid therapy. Repeat semen analysis demonstrated a significant increase in sperm count, allowing sperm banking to take place. CONCLUSION(S): High-dose corticosteroid therapy may be indicated in testicular sarcoidosis, not only for control of systemic disease activity but also for recovery of gonadal function and spermatogenesis.


Assuntos
Corticosteroides/uso terapêutico , Oligospermia/etiologia , Sarcoidose/complicações , Sarcoidose/tratamento farmacológico , Doenças Testiculares/complicações , Doenças Testiculares/tratamento farmacológico , Corticosteroides/administração & dosagem , Adulto , Relação Dose-Resposta a Droga , Hormônio Foliculoestimulante/sangue , Humanos , Hormônio Luteinizante/sangue , Masculino , Sarcoidose/sangue , Sarcoidose/fisiopatologia , Contagem de Espermatozoides , Espermatogênese/efeitos dos fármacos , Doenças Testiculares/sangue , Doenças Testiculares/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...